{"DataElement":{"publicId":"7997765","version":"1","preferredName":"Patient Therapeutic Clinical Trial Use Sequence Enrollment Eligibility Determination Indicator","preferredDefinition":"The indicator for determining if sequencing results are used to enroll a patient on a therapeutic clinical trial.","longName":"PtntThryClinTrlSeqEnrlEligInd","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7997471","version":"1","preferredName":"Patient Therapeutic Clinical Trial Use Sequence Analysis Enrollment","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.:A clinical study that involves administering of exposure to the agent/agents to subjects with particular disease to elucidate the most appropriate treatment for a specific medical condition, or to prolong or improve the patient's life._A manner, or usual, or accepted practice of using something._The determination of the sequence of component residues in a macromolecule, e.g. amino acids in a protein or nucleotide bases in DNA/RNA or the computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA._The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.","longName":"PtntThrpyClinTrialUseSequEnrl","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11479377","version":"1","preferredName":"Therapeutic Clinical Trial Use Sequence Analysis Enrollment","preferredDefinition":"A clinical study that involves administering of exposure to the agent/agents to subjects with particular disease to elucidate the most appropriate treatment for a specific medical condition, or to prolong or improve the patient's life._A manner, or usual, or accepted practice of using something._The determination of the sequence of component residues in a macromolecule, e.g. amino acids in a protein or nucleotide bases in DNA/RNA or the computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA._The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.","longName":"C39536:C25340:C17565:C37948","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Clinical Trial","conceptCode":"C39536","definition":"A clinical study that involves administering of exposure to the agent/agents to subjects with particular disease to elucidate the most appropriate treatment for a specific medical condition, or to prolong or improve the patient's life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Use","conceptCode":"C25340","definition":"A manner, or usual, or accepted practice of using something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sequence Analysis","conceptCode":"C17565","definition":"The determination of the sequence of component residues in a macromolecule, e.g. amino acids in a protein or nucleotide bases in DNA/RNA or the computational analysis performed to determine the similarities between nonidentical proteins or molecules of DNA or RNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Enrollment","conceptCode":"C37948","definition":"The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB55C9E1-DE80-3644-E053-731AD00A88A8","latestVersionIndicator":"Yes","beginDate":"2022-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-18","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4CBD4AD-F586-67B9-E053-4EBD850A1622","latestVersionIndicator":"Yes","beginDate":"2022-01-04","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-04","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":"Created for MCI","administrativeNotes":"2022.10.18 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7997762","version":"1","preferredName":"Eligibility Determination Indicator","preferredDefinition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"7997762v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3216924","version":"1","preferredName":"No","longName":"3216924v1.00","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9FB8B94D-C670-2CB0-E040-BB89AD4377A2","latestVersionIndicator":"Yes","beginDate":"2011-03-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2011-03-30","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4DB35A5-348D-5B26-E053-4EBD850A2758","beginDate":"2022-01-05","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-05","modifiedBy":"ONEDATA","dateModified":"2022-01-05","deletedIndicator":"No"},{"value":"Yes, on a non-COG clinical trial","valueDescription":"Yes, on a non-COG clinical trial","ValueMeaning":{"publicId":"7997763","version":"1","preferredName":"Yes, on a non-COG clinical trial","longName":"7997763v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes._The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical Trial","conceptCode":"C71104","definition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4DB35A5-3497-5B26-E053-4EBD850A2758","latestVersionIndicator":"Yes","beginDate":"2022-01-05","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-05","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4DB35A5-34B0-5B26-E053-4EBD850A2758","beginDate":"2022-01-05","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-05","modifiedBy":"ONEDATA","dateModified":"2022-01-05","deletedIndicator":"No"},{"value":"Yes, on a COG clinical trial","valueDescription":"Yes, on a COG clinical trial","ValueMeaning":{"publicId":"7997764","version":"1","preferredName":"Yes, on a COG clinical trial","longName":"7997764v1.00","preferredDefinition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers._A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes._The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Children's Oncology Group","conceptCode":"C39353","definition":"An NCI-supported clinical cooperative group formed by the merger of the four national pediatric cancer research organizations: the Children's Cancer Group, the Intergroup Rhabdomyosarcoma Study Group, the National Wilms Tumor Study Group, and the Pediatric Oncology Group. The primary objective of the organization is to conduct clinical trials of new therapies for childhood and adolescent cancer. COG develops and coordinates clinical trials conducted at the 238 member institutions that include cancer centers of all major universities and teaching hospitals throughout the U.S. and Canada, as well as sites in Europe and Australia. COG members include over 5000 cancer researchers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical Trial","conceptCode":"C71104","definition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4DB35A5-34BA-5B26-E053-4EBD850A2758","latestVersionIndicator":"Yes","beginDate":"2022-01-05","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-05","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D4DB35A5-34D3-5B26-E053-4EBD850A2758","beginDate":"2022-01-05","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-05","modifiedBy":"ONEDATA","dateModified":"2022-01-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"11479370","version":"1","preferredName":"Eligibility Determination Indicator","preferredDefinition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"11479370v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB5521D9-79E7-1C38-E053-731AD00AB890","latestVersionIndicator":"Yes","beginDate":"2022-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-10-18","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4DB35A5-3478-5B26-E053-4EBD850A2758","latestVersionIndicator":"Yes","beginDate":"2022-01-05","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-05","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":"Created for APEC14B1 MCI","administrativeNotes":"2022.10.18 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Were sequencing results used to enroll a patient on a therapeutic clinical trial?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Did the patient enroll on a therapeutic clinical trial that utilized these sequencing results for eligibility or treatment assignment?","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4DB35A5-34E5-5B26-E053-4EBD850A2758","latestVersionIndicator":"Yes","beginDate":"2022-01-05","endDate":null,"createdBy":"BROWNTY","dateCreated":"2022-01-05","modifiedBy":"KUMMEROA","dateModified":"2022-10-18","changeDescription":"Created for APEC14B1 MCI","administrativeNotes":"2022.10.18 Reviewed and released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}